Your browser doesn't support javascript.
loading
AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer.
Kabraji, Sheheryar; Solé, Xavier; Huang, Ying; Bango, Clyde; Bowden, Michaela; Bardia, Aditya; Sgroi, Dennis; Loda, Massimo; Ramaswamy, Sridhar.
Afiliação
  • Kabraji S; Massachusetts General Hospital Cancer Center, Richard B. Simches Research Building, 185 Cambridge Street, Boston, MA, 02114, USA.
  • Solé X; Harvard Medical School, Boston, MA, USA.
  • Huang Y; Massachusetts General Hospital Cancer Center, Richard B. Simches Research Building, 185 Cambridge Street, Boston, MA, 02114, USA.
  • Bango C; Harvard Medical School, Boston, MA, USA.
  • Bowden M; Present address: Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain.
  • Bardia A; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sgroi D; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Loda M; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ramaswamy S; Massachusetts General Hospital Cancer Center, Richard B. Simches Research Building, 185 Cambridge Street, Boston, MA, 02114, USA.
Breast Cancer Res ; 19(1): 88, 2017 Aug 01.
Article em En | MEDLINE | ID: mdl-28764807
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Terapia Neoadjuvante / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Mama Triplo Negativas Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Terapia Neoadjuvante / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Mama Triplo Negativas Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article